AAVnerGene at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
AAVnerGene brings 4 presentations to ESGCT 2026 in Hamburg. Its contributions pair new AAV capsids with production and testing tools, including variants that target the choroid plexus in the brain and lung resident macrophages. Other work covers a single-plasmid production platform that raises full particle content and an assay for AAV infectivity.
| Organization | ESGCT 2026 Attendance |
|---|---|
AAVnerGene Rockville, Maryland | |
Supplies AAV vectors, plasmids, capsid engineering and analytical services, and the AAVone single-plasmid AAV production system. | Poster Wed Oct 28 1:30pm–3:30pm AAV-ChP: A Novel AAV Capsid with Specific Tropism for Choroid Plexus in Mice after ICV Administration Poster Thu Oct 29 2:00pm–4:00pm AAVone2.1 single-plasmid platform enables >80% full AAV particles and titers up to 1 × 10^16 vg/L across diverse capsids Poster Thu Oct 29 2:00pm–4:00pm Development of an Accurate, Sensitive, and Safe TCID50 Assay for Quantitative Measurement of AAV Infectivity Poster Thu Oct 29 2:00pm–4:00pm Highly lung-tropic AAV-ShD selectively targets F4/80 positive lung resident macrophages |
Instantly find 20 buyers from AAVnerGene
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction